The Systemic Nature of Sexual Functioning in the Postmenauposal Woman: Crossroads of Psychiatry and Gynecology

Primary Psychiatry

Volumn 10, Issue 12, 2003, Pages 53-57

  Alexander, Jeanne Leventhal ^a,b,c,h   Kotz, Krista ^d   Dennerstein, Lorraine ^e   Davis, Susan R ^f,g  

^a Permanente Med Grp N California   (United States)

^b Alexander Foundation for Women's Health   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Kotz Health Policy Consulting   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

^g Jean Hailes Foundation for Women's Health   (Australia)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; SEX HORMONE; TESTOSTERONE;

CLIMACTERIUM; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; POSTMENOPAUSE; REVIEW; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SOCIAL PSYCHOLOGY;

EID: 1842507885     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Basson R. The female sexual response: a different model. J Sex Marital Ther. 2000;1:51-65.
2. Leiblum SR, Wiegel M. Psychotherapeutic interventions for treating female sexual dysfunction. World J Urol. 2002;2:127-136.
3. Basson R. A model of women's sexual arousal. J Sex Marital Ther. 2002;1:1-10.
4. Basson R. Women's sexual desire-disordered or misunderstood? J Sex Marital Ther. 2002;28 (suppl 1):17-28.
5. Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol. 2000;3:888-893.
6. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
7. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;6:537-544.
8. Fugl-Meyer AR, Fugl-Meyer KS. Sexual disabilities, problems, and satisfaction in 18-74 year old Swedes. Scand J Sexology. 1999;2:79-105.
9. Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract. 1998;6:519-524.
10. Osborn M, Hawton K, Gath D. Sexual dysfunction among middle aged women in the community. Br Med J (Clin Res Ed). 1988;6627:959-962.
11. Bancroft J. The medicalization of female sexual dysfunction: the need for caution. Arch Sex Behav. 2002;5:451-455.
12. Dennerstein L, Lehert P, Burger H, et al. Biological and psychosocial factors affecting sexual functioning during the menopausal transition. In: Bellino F, ed. Biology of Menopause. New York, NY: Springer-Verlag; 2000:211-222.
13. Hallstrom T. Sexuality in the climacteric. Clin Obstet Gynaecol. 1977;1:227-239.
14. Hallstrom T, Samuelsson S. Changes in women's sexual desire in middle life: the longitudinal study of women in Gothenburg. Arch Sex Behav. 1990;3:259-268.
15. Pfeiffer E, Davis GC. Determinants of sexual behavior in middle and old age. J Am Geriatr Soc. 1972;4:151-158.
16. Dennerstein L, Randolph J, Taffe J, et al. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril. 2002;77(suppl 4):42-48.
17. Levine SB. More on the nature of sexual desire. J Sex Marital Ther. 1987;1:35-44.
18. Bachmann G. Female sexuality and hormone replacement: a focus on androgen insufficiency. In: Proceedings of the 4th Task Force on Female Sexuality. Paramus, NJ: MPE Communications; 2002:11-12.
19. Pariser SF, Niedermier JA. Sex and the mature woman. J Womens Health. 1998;7:849-859.
20. Morgan CD, Wiederman MW, Pryor TL. Sexual functioning and attitudes of eating-disordered women: a follow-up study. J Sex Marital Ther. 1995;2:67-77.
21. Clayton AH, McGarvey EL, Abouesh AI, et al. Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry. 2001;3:185-190.
22. Zumoff B, Strain GW, Miller LK, et al. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 1995;4:1429-1430.
23. Burger HG, Dudley EC, Cui J, et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;8:2832-2838.
24. Labrie F, Belanger A, Cusan L, et al. Marked decline in serum concentrations of adrenal C 19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab. 1997;8:2396-2402.
25. Zumoff B, Walsh BT, Katz JL, et al. Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrinol Metab. 1983;4:668-672.
26. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, et al. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2000;2:645-651.
27. Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. J Womens Health Gend Based Med. 2000;9(suppl 1):S25-S32.
28. Sarrel PM. Sexuality and menopause. Obstet Gynecol. 1990;75(suppl 4):26S-35S.
29. Lang WR, Aponte GE. Gross and microscopic anatomy of the aged female reproductive organs. Clin Obstet Gynecol. 1967;3:454-465.
30. Sarrel PM. Sexuality in the middle years. Obstet Gynecol Clin North Am. 1987;1:49-62.
31. Gescheider GA, Verrillo RT, McCann JT, et al. Effects of the menstrual cycle on vibrotactile sensitivity. Percept Psychophys. 1984;6:586-592.
32. Parlee MB. Menstrual rhythms in sensory processes: a review of fluctuations in vision, olfaction, audition, taste, and touch. Psychol Bull. 1983;3:539-548.
33. Sarrel P, Marks L, Schwartz-Giblin S. Sex hormones and senses. In: Zichella L, Whitehead M, van Keep P, eds. The Climacteric and Beyond. Pearl River, NJ: Parthenon; 1988.
34. Kow L, Pfaff D. Effects of oestrogen treatment on the size of receptive field and response threshold of pudendal nerve in the female rat. Neuroendocrinology. 1973;13:299-313.
35. Rauramo L. Estrogens and psychic function. In: van Keep P, Lauritzen C, eds. Aging and Estrogens, Frontiers of Hormone Research. Karger, Basel; 1973:118-133.
36. Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;3:351-358.
37. Traish AM, Kim N, Min K, et al. Role of androgens in female genital sexual arousal: receptor expression, structure, and function. Fertil Steril. 2002;77(suppl 4):11-18.
38. Myers LS, Morokoff PJ. Physiological and subjective sexual arousal in pre- and postmenopausal women and postmenopausal women taking replacement therapy. Psychophysiology. 1986;3:283-292.
39. Sarrel PM. Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of postmenopausal women. Int J Impot Res. 1998;10(suppl 2):S91-S93.
40. Sourla A, Flamand M, Belanger A, et al. Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat. J Steroid Biochem Mol Biol. 1998;3:137-149.
41. Kennedy TG, Armstrong DT. Induction of vaginal mucification in rats with testosterone and 17β-hydroxy-5α-androstan-3-one. Steroids. 1976;3:423-430.
42. Kennedy TG. Vaginal mucification in the ovariectomized rat in response to 5α-pregnane-3,20-dione, testosterone and 5α-androstan-17β -ol-3-one: test for progestogenic activity. J Endocrinol. 1974;2:293-300.
43. Kennedy TG. Proceedings: Vaginal mucification in the ovariectomized rat in response to 5α-pregnan-3,20-dione, testosterone and 5α-androstan-17β-ol-3-one: test for progestagenic activity. J Reprod Fertil. 1974;2:488-489.
44. Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry. 1996;8:974-984.
45. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry. 1998;9:839-850.
46. Bixo M, Backstrom T, Winblad B, et al. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol. 1995;55:297-303.
47. Wakatsuki A, Sagara Y. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol. 1995;4:523-528.
48. Van Goozen SH, Cohen-Kettenis PT, Gooren LJ, et al. Gender differences in behaviour: activating effects of cross-sex hormones. Psychoneuroendocrinology. 1995;4:343-363.
49. Dennerstein L, Burrows GD, Wood C, et al. Hormones and sexuality: effect of estrogen and progestogen. Obstet Gynecol. 1980;3:316-322.
50. Nathorst-Boos J, Wiklund I, Mattsson LA, et al. Is sexual life influenced by transdermal estrogen therapy? A double-blind placebo-controlled study in postmenopausal women. Acta Obstet Gynecol Scand. 1993;8:656-660.
51. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol. 1993;168:824-830.
52. Myers LS, Dixen J, Morrissette D, et al. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab. 1990;4:1124-1131.
53. Notelovitz M, Mattox JH. Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17β-estradiol. Menopause. 2000;5:310-317.
54. Rebar RW, Trabal J, Mortola J. Low-dose esterified estrogens (0.3 mg/day): Long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women. Climacteric. 2000;3:176-182.
55. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med. 1998;10:847-856.
56. Davis SR, McCloud P, Strauss BJ, et al. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 1995;3:227-236.
57. Sherwin BB. Changes in sexual behavior as a function of plasma sex steroid levels in postmenopausal women. Maturitas. 1985;3:225-233.
58. Lobo RA, Rosen RC, Yang H, et al. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril. 2003;6:1341-1352.
59. Burger H, Hailes J, Nelson J, et al. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. Br Med J (Clin Res Ed). 1987;294:936-937.
60. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1987;4:397-409.
61. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy [see comments]. N Engl J Med. 2000;10:682-688.
62. Floter A, Nathorst-Boos J, Carlstrom K, et al. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric. 2002;4:357-365.
63. Bancroft J, Sanders D, Warner P, et al. The effects of oral contraceptives on mood and sexuality: a comparison of triphasic and combined preparations. J Psychosom Obstet Gynaecol. 1987;7:1-8.
64. Basson R. The complexities of female sexual arousal disorder: potential role of pharmacotherapy. World J Urol. 2002;2:119-126.
65. Basson R. Are our definitions of women's desire, arousal and sexual pain disorders too broad and our definition of orgasmic disorder too narrow? J Sex Marital Ther. 2002;4:289-300.
66. Basson R. Rethinking low sexual desire in women. Bjog. 2002;4:357-363.
67. Bachmann G, Bancroft J, Braunstein G, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril. 2002;4:660-665.